SEC Form 4 · accession 0001209191-16-130775
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C Dreyer
Officer — SVP / Chief Financial Officer
Period of report
Jul 1, 2016
Accepted (ET)
Jul 5, 2016 · 2:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2016 | M | 70,000 | — | A | 123,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jul 1, 2016 | M | 70,000 | D | — | — | Common Stock | 70,000 | 0 | D |
Explanation of responses
- F1Restricted stock units covert into common stock on a one-for-one basis.
- F2On March 10, 2016, the reporting person was granted 70,000 restricted stock units, all of which vested on July 1, 2016.